<code id='D6F6EE2909'></code><style id='D6F6EE2909'></style>
    • <acronym id='D6F6EE2909'></acronym>
      <center id='D6F6EE2909'><center id='D6F6EE2909'><tfoot id='D6F6EE2909'></tfoot></center><abbr id='D6F6EE2909'><dir id='D6F6EE2909'><tfoot id='D6F6EE2909'></tfoot><noframes id='D6F6EE2909'>

    • <optgroup id='D6F6EE2909'><strike id='D6F6EE2909'><sup id='D6F6EE2909'></sup></strike><code id='D6F6EE2909'></code></optgroup>
        1. <b id='D6F6EE2909'><label id='D6F6EE2909'><select id='D6F6EE2909'><dt id='D6F6EE2909'><span id='D6F6EE2909'></span></dt></select></label></b><u id='D6F6EE2909'></u>
          <i id='D6F6EE2909'><strike id='D6F6EE2909'><tt id='D6F6EE2909'><pre id='D6F6EE2909'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:82973
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          BIO to announce reorganization, senior leaders expected to depart
          BIO to announce reorganization, senior leaders expected to depart

          BIOisproceedingwitharestructuringafteritsnewCEOtookover.LaneTurner/TheBostonGlobeWASHINGTON—T

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Cigna to pay $172 million to settle Medicare Advantage fraud probe

          JuliaRendleman/GettyImagesforEventiveMarketingHealthinsurerCignaispayingmorethan$172milliontosettlea